DRI Healthcare Trust (TSE:DHT.UN) Receives C$18.00 Average Price Target from Brokerages

DRI Healthcare Trust (TSE:DHT.UN) has been assigned an average rating of “Moderate Buy” from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is C$18.00.

A number of analysts recently issued reports on DHT.UN shares. Scotiabank raised their price target on DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Raymond James dropped their price target on shares of DRI Healthcare Trust from C$23.00 to C$22.00 in a research note on Wednesday, November 13th.

DRI Healthcare Trust Stock Up 43.1 %

TSE:DHT.UN opened at C$13.09 on Thursday. The business has a 50 day simple moving average of C$13.41 and a 200-day simple moving average of C$13.35. DRI Healthcare Trust has a 1 year low of C$10.39 and a 1 year high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, October 18th were issued a dividend of $0.085 per share. The ex-dividend date was Friday, September 27th. This represents a $0.34 dividend on an annualized basis and a yield of 2.60%. DRI Healthcare Trust’s payout ratio is -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.